WAS
ONC

WESPAC Advisors SoCal’s BeOne Medicines Ltd ONC Stock Holding History

WESPAC Advisors SoCal’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Buy
5,082
+157
+3% +$46.3K 0.26% 71
2026
Q1 		$1.46M Buy
4,925
+1,968
+67% +$637K 0.31% 68
2025
Q4 		$898K Sell
2,957
-158
-5% -$51.7K 0.18% 80
2025
Q3 		$1.06M Buy
+3,115
New +$946K 0.22% 72

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

WESPAC Advisors SoCal's ONC Position: Q2 2026 in Review

WESPAC Advisors SoCal increased its BeOne Medicines Ltd (ONC) stake by 3.2% in Q2 2026, buying an estimated $46.3K and bringing the position to 5,082 shares worth $1.45M. The position accounts for 0.26% of the portfolio, ranked #71.

WESPAC Advisors SoCal first reported a position in ONC in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.46M in Q1 2026. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • WESPAC Advisors SoCal held 5,082 shares of BeOne Medicines Ltd worth $1.45M as of Q2 2026.
  • WESPAC Advisors SoCal bought 157 BeOne Medicines Ltd shares in Q2 2026, an estimated $46.3K.
  • BeOne Medicines Ltd made up 0.26% of WESPAC Advisors SoCal's portfolio in Q2 2026, its #71 holding.
  • WESPAC Advisors SoCal first reported a position in BeOne Medicines Ltd in Q3 2025 and has held it in 4 quarters since.
  • WESPAC Advisors SoCal's BeOne Medicines Ltd position peaked at $1.46M in Q1 2026.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on WESPAC Advisors SoCal's 13F filing for Q2 2026, filed 16 Jul 2026.